Optimizing ADC value beyond approval through model-informed strategies Originally aired: Thursday, April 2, 2026 As antibody–drug conjugates (ADCs) move from…
Leveraging adaptive clinical trial designs in oncology allows researchers to adjust predefined study elements based on accumulating data, such as…
Writing pharmacokinetic (PK) reports can feel like a marathon – copying tables, double-checking numbers, and wrestling with formatting that eats…
Clinical Pharmacology Leader, Ionis Pharmaceuticals Pratap Singh, Ph.D., is currently an Executive Director and Franchise head within the Clinical pharmacology…
Sign in to your account